NASDAQ : ALNY
Alnylam Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 165 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 22.10B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alnylam Pharmaceuticals, Inc. (ALNY) reported revenue of 5.01B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 5.01B | 3.71B | 2.25B | 1.83B | 1.04B | 844.29M |
| Cost of Revenue | 1.14B | 681.87M | 323.37M | 310.41M | 168.82M | 140.14M |
| Gross Profit | 3.87B | 3.03B | 1.92B | 1.52B | 868.60M | 704.14M |
| Selling, General & Admin | 1.34B | 1.21B | 975.53M | 795.65M | 770.66M | 620.64M |
| Research & Development | 1.56B | 1.32B | 1.13B | 1.00B | 883.01M | 792.16M |
| Operating Expenses | 2.90B | 2.53B | 2.10B | 1.80B | 1.65B | 1.41B |
| Operating Income | 977.59M | 501.58M | -176.88M | -282.18M | -785.07M | -708.65M |
| Interest Expense | -301.11M | -252.63M | -141.86M | -121.22M | -155.97M | -143.02M |
| Interest & Investment Income | 112.31M | 111.47M | 121.99M | 95.56M | 24.81M | 1.58M |
| Other Non Operating Income (Expenses) | -46.41M | -34.96M | -177.60M | -108.74M | -100.86M | -57.74M |
| EBT Excluding Unusual Items | 742.38M | 325.46M | -374.35M | -416.57M | -1.02B | -907.84M |
| Gain (Loss) on Sale of Investments | -2.31M | -3.02M | -16.94M | -33.31M | 55.70M | |
| Other Unusual Items | 39.15M | -76.59M | ||||
| Pretax Income | 781.53M | 323.15M | -377.38M | -433.52M | -1.13B | -852.14M |
| Income Tax Expense | -1.87B | 9.40M | -99.22M | 6.72M | 4.16M | 680.00K |
| Net Income | 2.65B | 313.75M | -278.16M | -440.24M | -1.13B | -852.82M |
| Net Income to Common | 2.65B | 313.75M | -278.16M | -440.24M | -1.13B | -852.82M |
| Shares Outstanding (Basic) | 133.14M | 131.00M | 127.65M | 124.91M | 121.69M | 118.45M |
| Shares Outstanding (Diluted) | 137.71M | 134.68M | 127.65M | 124.91M | 121.69M | 118.45M |
| EPS (Basic) | 19.90 | 2.39 | -2.18 | -3.52 | -9.30 | -7.20 |
| EPS (Diluted) | 19.29 | 2.33 | -2.18 | -3.52 | -9.30 | -7.20 |
| Free Cash Flow | 806.31M | 465.38M | -42.59M | 41.95M | -613.33M | -718.07M |
| Free Cash Flow Per Share | 5.86 | 3.46 | -0.33 | 0.34 | -5.04 | -6.06 |
| Gross Margin | 77.28% | 81.64% | 85.62% | 83.02% | 83.73% | 83.40% |
| Operating Margin | 19.50% | 13.51% | -7.87% | -15.43% | -75.68% | -83.94% |
| Profit Margin | 52.85% | 8.45% | -12.37% | -24.08% | -109.04% | -101.01% |
| Free Cash Flow Margin | 16.08% | 12.53% | -1.89% | 2.29% | -59.12% | -85.05% |
| EBITDA | 1.03B | 557.24M | -120.22M | -228.12M | -740.60M | -661.09M |
| EBITDA Margin | 20.61% | 15.00% | -5.35% | -12.48% | -71.39% | -78.30% |
| D&A For EBITDA | 55.43M | 55.66M | 56.67M | 54.05M | 44.47M | 47.57M |
| EBIT | 977.59M | 501.58M | -176.88M | -282.18M | -785.07M | -708.65M |
| EBIT Margin | 19.50% | 13.51% | -7.87% | -15.43% | -75.67% | -83.94% |
| Effective Tax Rate | 2.91% | |||||
| Revenue as Reported | 5.01B | 3.71B | 2.25B | 1.83B | 1.04B | 844.29M |
| Advertising Expenses | 36.00M | 29.70M | 12.40M | 11.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.75B | 1.66B | 966.43M | 812.69M | 866.39M | 819.98M |
| Short-Term Investments | 1.83B | 1.25B | 1.73B | 1.63B | 1.33B | 1.62B |
| Cash & Short-Term Investments | 3.59B | 2.91B | 2.69B | 2.44B | 2.19B | 2.44B |
| Accounts Receivable | 1.08B | 777.57M | 405.31M | 327.79M | 237.96M | 198.57M |
| Receivables | 1.08B | 777.57M | 405.31M | 327.79M | 237.96M | 198.57M |
| Inventory | 105.91M | 82.72M | 78.51M | 89.15M | 128.96M | 86.36M |
| Prepaid Expenses | 334.60M | 281.89M | 116.96M | 126.38M | 132.92M | 88.08M |
| Total Current Assets | 5.11B | 4.05B | 3.30B | 2.98B | 2.69B | 2.81B |
| Property, Plant & Equipment | 792.86M | 708.06M | 693.93M | 725.79M | 738.63M | 733.63M |
| Long-Term Deferred Tax Assets | 2.01B | 125.97M | 116.86M | 10.10M | ||
| Other Long-Term Assets | 82.48M | 81.63M | 133.90M | 111.29M | 115.48M | 101.09M |
| Total Assets | 7.99B | 4.97B | 4.24B | 3.83B | 3.55B | 3.64B |
| Accounts Payable | 135.40M | 115.72M | 88.42M | 55.52M | 98.09M | 73.43M |
| Accrued Expenses | 1.24B | 821.34M | 701.38M | 654.73M | 513.78M | 372.33M |
| Current Portion of Long-Term Debt | 633.57M | 220.07M | 113.02M | 54.99M | 40.29M | 37.08M |
| Current Portion of Leases | 46.08M | 45.52M | 41.89M | 41.51M | 41.97M | 40.55M |
| Current Unearned Revenue | 11.67M | 4.84M | 55.48M | 102.75M | 42.10M | 149.48M |
| Other Current Liabilities | 258.86M | 186.09M | 58.28M | 31.68M | 22.84M | |
| Total Current Liabilities | 2.06B | 1.47B | 1.19B | 967.79M | 767.91M | 695.71M |
| Long-Term Debt | 2.11B | 2.48B | 2.36B | 2.34B | 2.27B | 1.83B |
| Long-Term Leases | 203.29M | 225.09M | 229.54M | 243.10M | 261.34M | 281.35M |
| Long-Term Unearned Revenue | 188.18M | 193.79M | 152.36M | |||
| Other Long-Term Liabilities | 10.61M | 7.59M | 398.11M | 308.44M | 212.58M | 98.96M |
| Total Liabilities | 4.39B | 4.18B | 4.17B | 4.05B | 3.70B | 3.06B |
| Common Stock | 1.34M | 1.32M | 1.29M | 1.26M | 1.24M | 1.20M |
| Additional Paid-In Capital | 7.81B | 7.51B | 7.39B | 6.81B | 6.45B | 6.06B |
| Retained Earnings | -4.16B | -6.70B | -7.29B | -7.01B | -6.57B | -5.44B |
| Comprehensive Income & Other | -44.66M | -20.10M | -34.52M | -23.38M | -44.65M | -33.26M |
| Shareholders' Equity | 3.60B | 789.18M | 67.09M | -220.64M | -158.22M | 588.20M |
| Total Liabilities & Equity | 7.99B | 4.97B | 4.24B | 3.83B | 3.55B | 3.64B |
| Total Debt | 3.00B | 2.97B | 2.74B | 2.68B | 2.61B | 2.19B |
| Net Cash (Debt) | 590.40M | -60.31M | -48.91M | -243.24M | -420.15M | 249.87M |
| Net Cash Per Share | 4.29 | -0.45 | -0.38 | -1.95 | -3.45 | 2.11 |
| Filing Date Shares Outstanding | 133.94M | 132.62M | 129.46M | 125.95M | 124.13M | 120.21M |
| Total Common Shares Outstanding | 133.88M | 132.38M | 129.29M | 125.79M | 123.92M | 120.18M |
| Working Capital | 3.05B | 2.58B | 2.11B | 2.01B | 1.92B | 2.11B |
| Book Value Per Share | 26.92 | 5.96 | 0.52 | -1.75 | -1.28 | 4.89 |
| Tangible Book Value | 3.60B | 789.18M | 67.09M | -220.64M | -158.22M | 588.20M |
| Tangible Book Value Per Share | 26.92 | 5.96 | 0.52 | -1.75 | -1.28 | 4.89 |
| Land | 9.08M | 9.08M | 9.08M | 9.08M | 9.08M | |
| Buildings | 297.62M | 294.51M | 271.65M | 269.32M | 262.64M | |
| Machinery | 247.12M | 225.20M | 202.89M | 173.10M | 137.86M | |
| Construction In Progress | 40.95M | 7.67M | 30.10M | 14.60M | 80.75M | |
| Leasehold Improvements | 241.08M | 236.69M | 235.41M | 230.85M | 152.04M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 2.65B | 313.75M | -278.16M | -440.24M | -1.13B | -852.82M |
| Depreciation & Amortization | 55.43M | 55.66M | 56.67M | 54.05M | 44.47M | 89.69M |
| Loss (Gain) From Sale of Investments | 2.31M | 3.02M | 16.94M | 33.31M | -55.70M | |
| Stock-Based Compensation | 307.53M | 348.24M | 272.08M | 221.68M | 230.65M | 165.72M |
| Other Operating Activities | -1.61B | 248.92M | 152.15M | 194.46M | 273.83M | 174.24M |
| Change in Accounts Receivable | -129.05M | -359.96M | -86.55M | -87.94M | -45.60M | -101.80M |
| Change in Inventory | -15.99M | 8.47M | 13.59M | 18.37M | -34.14M | -26.41M |
| Change in Accounts Payable | -139.13M | 75.07M | 91.09M | 80.84M | 191.77M | 88.24M |
| Change in Unearned Revenue | 9.13M | -50.63M | -235.45M | 55.02M | -65.91M | -50.40M |
| Change in Other Net Operating Assets | -173.09M | -117.72M | 3.23M | -9.03M | -38.51M | -72.44M |
| Operating Cash Flow | 955.94M | 524.08M | -8.31M | 104.16M | -541.27M | -641.69M |
| Capital Expenditures | -149.64M | -58.70M | -34.28M | -62.21M | -72.06M | -76.37M |
| Investment in Securities | -607.59M | 497.18M | -63.25M | -269.70M | 254.61M | -192.56M |
| Other Investing Activities | 19.32M | -2.15M | -19.32M | -4.44M | -13.19M | -4.36M |
| Investing Cash Flow | -737.90M | 436.33M | -116.84M | -336.35M | 169.35M | -273.30M |
| Long-Term Debt Issued | 645.69M | 1.02B | 500.00M | |||
| Long-Term Debt Repaid | -1.19B | -880.72M | ||||
| Net Debt Issued (Repaid) | -52.93M | -546.95M | 135.39M | 500.00M | ||
| Issuance of Common Stock | 103.88M | 250.03M | 302.95M | 147.46M | 259.36M | 246.27M |
| Other Financing Activities | 10.49M | -8.27M | -8.79M | 24.67M | 31.00M | 500.85M |
| Financing Cash Flow | 61.44M | -305.19M | 294.16M | 172.13M | 425.75M | 1.25B |
| Foreign Exchange Rate Adjustments | -16.47M | 34.94M | -15.24M | 6.39M | -7.43M | -9.02M |
| Net Cash Flow | 263.01M | 690.15M | 153.77M | -53.67M | 46.40M | 323.11M |
| Free Cash Flow | 806.31M | 465.38M | -42.59M | 41.95M | -613.33M | -718.07M |
| Free Cash Flow Margin | 16.08% | 12.53% | -1.89% | 2.29% | -59.12% | -85.05% |
| Free Cash Flow Per Share | 5.86 | 3.46 | -0.33 | 0.34 | -5.04 | -6.06 |
| Levered Free Cash Flow | 327.23M | 128.79M | 197.88M | 103.55M | -444.35M | 97.11M |
| Unlevered Free Cash Flow | 515.43M | 286.68M | 286.54M | 179.32M | -346.87M | 186.50M |
| Cash Interest Paid | 254.71M | 218.71M | 67.58M | 32.12M | 45.23M | 24.66M |
| Cash Income Tax Paid | 48.63M | 21.20M | 9.31M | 2.57M | 2.65M | |
| Change in Working Capital | -448.14M | -444.78M | -214.08M | 57.26M | 7.62M | -162.82M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 22.10B | 52.54B | 30.35B | 24.02B | 29.24B | 20.28B |
| Enterprise Value | 21.51B | 52.58B | 30.30B | 24.28B | 29.56B | 19.87B |
| Last Close Price | 165.00 | 397.65 | 235.31 | 191.41 | 237.65 | 169.58 |
| PE Ratio | 8.55 | 167.44 | ||||
| Forward PE | 22.48 | 60.03 | ||||
| PS Ratio | 4.41 | 14.14 | 13.50 | 13.14 | 28.18 | 24.02 |
| PB Ratio | 6.13 | 66.57 | 452.40 | -108.87 | -184.79 | 34.48 |
| P/TBV Ratio | 6.13 | 66.57 | 452.40 | 34.48 | ||
| P/FCF Ratio | 27.41 | 112.89 | 572.67 | |||
| P/OCF Ratio | 23.12 | 100.24 | 230.62 | |||
| EV/Sales Ratio | 4.29 | 14.16 | 13.48 | 13.28 | 28.50 | 23.54 |
| EV/EBITDA Ratio | 20.82 | 94.36 | ||||
| EV/EBIT Ratio | 22.00 | 104.84 | ||||
| EV/FCF Ratio | 26.68 | 112.99 | 578.81 | |||
| Debt / Equity Ratio | 0.83 | 3.76 | 40.89 | -12.16 | -16.51 | 3.72 |
| Debt / EBITDA Ratio | 2.69 | 4.70 | ||||
| Debt / FCF Ratio | 3.72 | 6.38 | 63.96 | |||
| Net Debt / Equity Ratio | -0.16 | 0.08 | 0.73 | -1.10 | -2.65 | -0.42 |
| Net Debt / EBITDA Ratio | -0.57 | 0.11 | -0.41 | -1.07 | -0.57 | 0.38 |
| Net Debt / FCF Ratio | -0.73 | 0.13 | -1.15 | 5.80 | -0.69 | 0.35 |
| Asset Turnover | 0.78 | 0.81 | 0.56 | 0.50 | 0.29 | 0.24 |
| Inventory Turnover | 12.57 | 8.46 | 3.86 | 2.85 | 1.57 | 1.74 |
| Quick Ratio | 2.27 | 2.51 | 2.61 | 2.86 | 3.17 | 3.79 |
| Current Ratio | 2.48 | 2.76 | 2.78 | 3.08 | 3.51 | 4.04 |
| Return on Equity (ROE) | 138.07% | 73.28% | -526.14% | -106.31% | ||
| Return on Assets (ROA) | 9.51% | 6.81% | -2.74% | -4.78% | -13.65% | -12.56% |
| Return on Invested Capital (ROIC) | 48.31% | 57.33% | -10.01% | -50.38% | -132.10% | |
| Return on Capital Employed (ROCE) | 16.50% | 14.30% | -5.80% | -9.90% | -28.30% | -24.00% |
| Earnings Yield | 11.69% | 0.60% | -0.92% | -1.83% | -3.87% | -4.21% |
| FCF Yield | 3.65% | 0.89% | -0.14% | 0.18% | -2.10% | -3.54% |
| Buyback Yield / Dilution | -3.63% | -5.51% | -2.20% | -2.64% | -2.73% | -3.01% |